Yardeni Warns 'Buy The Dip' Strategy May Not Work Amid Fog Of War Due To Iran Conflict: Report

Published : Mar 16, 2026, 08:00 PM IST
https://stocktwits.com/news-articles/markets/equity/yardeni-warns-buy-the-dip-strategy-may-not-work-amid-iran-war/cZ32CZSRIfp

Synopsis

Yardeni explained that, unlike previous selloffs driven by economic cycles, this downturn risk is rooted in geopolitics, something policymakers may struggle to counter.

Economist Ed Yardeni, president of Yardeni Research, on Monday reportedly stated that the contrarian stock buying strategy, “Buy the Dip”, may not work amid the fog of war due to the Iran conflict.

During an interview with Bloomberg, Yardeni stated that, from a contrarian perspective, a declining sentiment increases the likelihood of a good buying opportunity ahead.

“It’s worked very well for me in the past. It may not work now,” he said.

Explaining why this time may be different, Yardeni said past declines in investor sentiment were typically tied to weakening economic fundamentals, developments that often resulted in monetary or fiscal policy support.

This time, however, the uncertainty stems from the Iran war, a geopolitical shock that policymakers have little ability to counter directly.

“We’re talking about the fog of war, we’re not talking about something that US policymakers can respond to and turn around,” Yardeni added in the interview.

Get updates to this developing story directly on Stocktwits.<

For updates and corrections, email newsroom[at]stocktwits[dot]com.<

PREV

Stay updated with all the latest Business News, including market trends, Share Market News, stock updates, taxation, IPOs, banking, finance, real estate, savings, and investments. Track daily Gold Price changes, updates on DA Hike, and the latest developments on the 8th Pay Commission. Get in-depth analysis, expert opinions, and real-time updates to make informed financial decisions. Download the Asianet News Official App from the Android Play Store and iPhone App Store to stay ahead in business.

Recommended Stories

HCWB Stock Soars Pre-Market On Positive Research Results For CAR-T Cell Therapy
Strategy Snaps Up $1.57B Of Bitcoin, Narrows Gap With BlackRock’s IBIT